SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Randy Schmid who wrote (2037)10/2/1997 9:39:00 PM
From: Oliver & Co   of 6136
 
Sure I can say.
In general the Merck people (one of the Florida supervisors is a personal friend) are the worst, they always have been. They think they are better than anybody, their attitude tends to be arrogant. I remember kicking one of them out of my office about four years ago, and she was a woman, and attractive. I understand that is how management is.
The Abbott guy is the best. Glaxo reps are so-so, they know that they have no real competition on their present formulary. Roche I rarely see.
And the AGPH man is a young, black, very intelligent guy, to the point, no bashing the competition (like Merck does). Very helpfull, a different approach.

I may buy some Oct. calls. Will see tomorrow.

Until later.

Oliver & Co.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News